Maria H Gilleece

12PUBLICATIONS
36CO-AUTHORS
Medical mycologyRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2021
Measurable residual disease status and outcome of transplant in acute myeloid leukemia in second complete remission: a study by the acute leukemia working party of the EBMT.

Maria H Gilleece, Avichai Shimoni, Myriam Labopin

|Dec 29, 2020
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia.

Charles Craddock, Aimee Jackson, Justin Loke

|Sep 15, 2020
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study.

Adrian J C Bloor, Amit Patel, James E Griffin

|Jul 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT.

Arnon Nagler, Frédéric Baron, Myriam Labopin

|Jul 01, 2020
A stitch in time saves nine… MRD-based pre-emptive therapy.

Maria H Gilleece, Bipin N Savani

|Jun 13, 2020
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

Eolia Brissot, Myriam Labopin, Frédéric Baron

Pageof 2

Frequent Collaborators

5 joint publications

Bipin N Savani

4 joint publications

Jamie Sanz

4 joint publications

Jenny Byrne

3 joint publications

Alexandros Spyridonidis